Overview


According to FutureWise analysis the market for Liver Cirrhosis Treatment in 2023 is US$ 7.07 billion, and is expected to reach US$ 16.45 billion by 2031 at a CAGR of 11.12%.

The liver is responsible for vital functions in the body such as protein synthesis, glucose metabolism, and detoxification of drugs and alcohol. A broad term for liver disease that describes all possible problems caused by the liver not performing its intended function is liver disease. There are four types of liver disease: cirrhosis (collection and storage of pus), liver cancer (hepatitis), liver cirrhosis (liver cirrhosis), liver cirrhosis (liver cancer), and liver hepatitis. Liver cirrhosis can be a result of liver disease, chronic alcoholism, non-alcoholic liver disease, or liver abscess (collection of pus). Liver cirrhosis can be characterized by abdominal pain, fatigue, and intestinal bleeding. It can also cause weight loss, jaundice, and weakness. There are four types of liver cirrhosis: hepatitis C-related cirrhosis; alcoholic cirrhosis; primary sclerosing cholangitis and primary biliary cirrhosis. A condition is known as liver cirrhosis, which is when the liver is severely damaged or scarred and leads to liver failure.

Major pharmaceutical companies are conducting a lot of research to find new drugs that can treat liver cirrhosis. People living a fast-paced lifestyle are at greater risk of liver cirrhosis. People with liver diseases such as hepatitis and cystic fibrosis, alcohol abuse, or alpha-1 antitrypsin deficiencies, are more at risk. The liver is responsible for many important functions, including the production of protein, metabolism of fat and carbohydrate, and detoxification of drugs and alcohol. The term liver disease covers all possible problems that can cause the liver not to perform its function. There are four types of liver disease: cirrhosis (collection and storage of pus), liver cancer, hepatitis, and cirrhosis. Liver cirrhosis refers to the late stages of scarring in the liver due to liver disease, chronic alcoholism, non-alcoholic fatty liver disease, and liver cancer. Liver cirrhosis symptoms include fatigue, abdominal pain, weight loss, jaundice, and intestinal bleeding. Cirrhosis can be caused by several conditions, including liver disease, hepatitis, and acute alcoholism.

It may also result from liver disease, liver disease, liver damage, iron buildup (hemochromatosis), severe liver diseases (Wilson's disease), poorly formed liver ducts (biliary ducts), alpha-1 Antitrypsin deficiency (biliary atresia), Inherited sugar metabolism disorders (galactosemia, glycogen storage disease), or glycogen storage disorder (alagille Syndrome) and other genetic digestive disorder (alagille), genetic digestion disorder (alagille), such as well as the final stage of the last. This is a severe staining of the liver that can lead to hepatic impairment and terminal stages of acute liver disease. This is usually caused by long-term exposure to viruses, such as alcohol and viral infections. The cause and severity of cirrhosis will determine the treatment. Late-stage liver cirrhosis, also known as liver cirrhosis, is a condition in which the liver is damaged by liver diseases such as chronic alcoholism and hepatitis. Scar tissue forms when the liver is damaged. The liver becomes more difficult to function as liver cirrhosis progresses. Although liver cirrhosis can't be reversed, it can be treated early and can be prevented from causing further damage.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Liver Cirrhosis Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Liver Cirrhosis Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Pfizer Inc
  • Abbott laboratories
  • Merck and Co
  • Novartis AG
  • Roche
  • Takeda Pharmaceuticals
  • Zydus Pharmaceuticals
  • Gilead Sciences Inc
  • Shionogi and Co. Ltd
  • Sanofi S.A.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Disease Type

  • Alcoholic Cirrhosis
  • Atrophic Cirrhosis
  • Biliary Cirrhosis
  • Crytogenic Cirrhosis

By Treatment Type

  • Immunosuppressants
  • Antibiotics
  • Vaccines
  • Anti-viral drugs
  • Corticosteroids

By Distribution Channel

  • Hospital Parmacy
  • Retail Pharmacy
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Liver Cirrhosis Treatment Market By Disease Type, By Treatment Type, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Liver Cirrhosis Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Liver Cirrhosis Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Liver Cirrhosis Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Liver Cirrhosis Treatment Market, By Disease Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Alcoholic Cirrhosis
        2. Atrophic Cirrhosis
        3. Biliary Cirrhosis
        4. Crytogenic Cirrhosis

  • 8.   Liver Cirrhosis Treatment Market, By Treatment Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Immunosuppressants
        2. Antibiotics
        3. Vaccines
        4. Anti-viral drugs
        5. Corticosteroids

  • 9.   Liver Cirrhosis Treatment Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Parmacy
        2. Retail Pharmacy
        3. Others

  • 10.   North America Liver Cirrhosis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Liver Cirrhosis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Liver Cirrhosis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Liver Cirrhosis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Liver Cirrhosis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Pfizer Inc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott laboratories
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck and Co
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Novartis AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Roche
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Takeda Pharmaceuticals
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Zydus Pharmaceuticals
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Gilead Sciences Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Shionogi and Co. Ltd
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Sanofi S.A.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients